Detalles de la búsqueda
1.
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Lancet Oncol
; 16(5): 583-94, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25892145
Resultados
1 -
1
de 1
1
Próxima >
>>